VOYA INVESTMENT MANAGEMENT LLC
Position in ELVN — Enliven Therapeutics, Inc.
CIK 1068837
ATLANTA, GA
Position in ELVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,778,489
+$3,210,442 QoQ
Shares Held
74,453
+413.8% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 210 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0%
Shared 11%
None 89%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. ELVN ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in ELVN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,778,489 | 74,453 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $568,047 | 14,491 | Shares | Defined | 2026-05-12 | |
| 2024-12-31 | $240,795 | 10,702 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $297,464 | 11,647 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $276,537 | 11,833 | Shares | Defined | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||